Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-21

Clinical Trial Update: Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study comparing generic tacrolimus to brand tacrolimus in stable kidney transplant recipients; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prograf (Tacrolimus)
  • Tacrolimus (generic) (Tacrolimus)

Snippet

Sponsor: Novartis | Conditions: Renal Transplant | Phase 4 | Status: COMPLETED | Results posted: 2012-06-21